Article ; Online: Harnessing sortase A transpeptidation for advanced targeted therapeutics and vaccine engineering.
2023 Volume 64, Page(s) 108108
Abstract: The engineering of potent prophylactic and therapeutic complexes has always required careful protein modification techniques with seamless capabilities. In this light, methods that favor unobstructed multivalent targeting and correct antigen ... ...
Abstract | The engineering of potent prophylactic and therapeutic complexes has always required careful protein modification techniques with seamless capabilities. In this light, methods that favor unobstructed multivalent targeting and correct antigen presentations remain essential and very demanding. Sortase A (SrtA) transpeptidation has exhibited these attributes in various settings over the years. However, its applications for engineering avidity-inspired therapeutics and potent vaccines have yet to be significantly noticed, especially in this era where active targeting and multivalent nanomedications are in great demand. This review briefly presents the SrtA enzyme and its associated transpeptidation activity and describes interesting sortase-mediated protein engineering and chemistry approaches for achieving multivalent therapeutic and antigenic responses. The review further highlights advanced applications in targeted delivery systems, multivalent therapeutics, adoptive cellular therapy, and vaccine engineering. These innovations show the potential of sortase-mediated techniques in facilitating the development of simple plug-and-play nanomedicine technologies against recalcitrant diseases and pandemics such as cancer and viral infections. |
---|---|
MeSH term(s) | Bacterial Proteins/metabolism ; Aminoacyltransferases/genetics ; Aminoacyltransferases/chemistry ; Aminoacyltransferases/metabolism ; Cysteine Endopeptidases/chemistry ; Cysteine Endopeptidases/metabolism ; Vaccines |
Chemical Substances | sortase A (EC 2.3.2.-) ; Bacterial Proteins ; Aminoacyltransferases (EC 2.3.2.-) ; Cysteine Endopeptidases (EC 3.4.22.-) ; Vaccines |
Language | English |
Publishing date | 2023-02-03 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 47165-3 |
ISSN | 1873-1899 ; 0734-9750 |
ISSN (online) | 1873-1899 |
ISSN | 0734-9750 |
DOI | 10.1016/j.biotechadv.2023.108108 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3730: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.